PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Researchers harness the immune system to improve stem cell transplant outcomes

2012-10-02
(Press-News.org) VIDEO: Dr. Amir Toor from Virginia Commonwealth University Massey Cancer Center's Bone Marrow Transplant program explains a recent clinical trial evaluating a new therapy for multiple myeloma that harnesses the power...
Click here for more information.

Richmond, Va. – (October 1, 2012) – A novel therapy in the early stages of development at Virginia Commonwealth University Massey Cancer Center shows promise in providing lasting protection against the progression of multiple myeloma following a stem cell transplant by making the cancer cells easier targets for the immune system.

Outlined in the British Journal of Hematology, the Phase II clinical trial was led by Amir Toor, M.D., hematologist-oncologist in the Bone Marrow Transplant Program and research member of the Developmental Therapeutics program at VCU Massey Cancer Center. The multi-phased therapy first treats patients with a combination of the drugs azacitidine and lenalidomide. Azacitidine forces the cancer cells to express proteins called cancer testis antigens (CTA) that immune system cells called T-cell lymphocytes recognize as foreign. The lenalidomide then boosts the production of T-cell lymphocytes. Using a process called autologous lymphocyte infusion (ALI), the T-cell lymphocytes are then extracted from the patient and given back to them after they undergo a stem cell transplant to restore the stem cells' normal function. Now able to recognize the cancer cells as foreign, the T-cell lymphocytes can potentially protect against a recurrence of multiple myeloma following the stem cell transplant.

"Every cell in the body expresses proteins on their surface that immune system cells scan like a barcode in order to determine whether the cells are normal or if they are foreign. Because multiple myeloma cells are spawned from bone marrow, immune system cells cannot distinguish them from normal healthy cells," says Toor. "Azacitidine essentially changes the barcode on the multiple myeloma cells, causing the immune system cells to attack them," says Toor.

The goal of the trial was to determine whether it was safe, and even possible, to administer the two drugs in combination with an ALI. In total, 14 patients successfully completed the investigational drug therapy. Thirteen of the participants successfully completed the investigational therapy and underwent a stem cell transplant. Four patients had a complete response, meaning no trace of multiple myeloma was detected, and five patients had a very good partial response in which the level of abnormal proteins in their blood decreased by 90 percent.

In order to determine whether the azacitidine caused an increased expression of CTA in the multiple myeloma cells, Toor collaborated with Masoud Manjili, D.V.M., Ph.D., assistant professor of microbiology and immunology at VCU Massey, to conduct laboratory analyses on bone marrow biopsies taken from trial participants before and after treatments. Each patient tested showed an over-expression of multiple CTA, indicating the treatment was successful at forcing the cancer cells to produce these "targets" for the immune system.

"We designed this therapy in a way that could be replicated, fairly inexpensively, at any facility equipped to perform a stem cell transplant," says Toor. "We plan to continue to explore the possibilities of immunotherapies in multiple myeloma patients in search for more effective therapies for this very hard-to-treat disease."

In addition to Manjili, Toor collaborated with John McCarty, M.D., director of the Bone Marrow Transplant Program at VCU Massey, and Harold Chung, M.D., William Clark, M.D., Catherine Roberts, Ph.D., and Allison Hazlett, also all from Massey's Bone Marrow Transplant Program; Kyle Payne, Maciej Kmieciak, Ph.D., from Massey and the Department of Microbiology and Immunology at VCU School of Medicine; Roy Sabo, Ph.D., from VCU Department of Biostatistics and the Developmental Therapeutics program at Massey; and David Williams, M.D., Ph.D., from the Department of Pathology at VCU School of Medicine, co-director of the Tissue and Data Acquisition and Analysis Core and research member of the Developmental Therapeutics program at Massey.

INFORMATION:

The full manuscript of this study can be found online at: http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2141.2012.09225.x/abstract;jsessionid=E1C7D245C01BA1228C06198A250BC990.d03t03

This research was supported, in part, with funding from VCU Massey Cancer Center's NIH-NCI Cancer Center Support Grant P30 CA016059.

News directors: Broadcast access to VCU Massey Cancer Center experts is available through VideoLink ReadyCam. ReadyCam transmits video and audio via fiber optics through a system that is routed to your newsroom. To schedule a live or taped interview, contact John Wallace, (804) 628-1550.

About VCU Massey Cancer Center

VCU Massey Cancer Center is one of only 67 National Cancer Institute-designated institutions in the country that leads and shapes America's cancer research efforts. Working with all kinds of cancers, the Center conducts basic, translational and clinical cancer research, provides state-of-the-art treatments and clinical trials, and promotes cancer prevention and education. Since 1974, Massey has served as an internationally recognized center of excellence. It has one of the largest offerings of clinical trials in Virginia and serves patients in Richmond and in six satellite locations. Its 1,000 researchers, clinicians and staff members are dedicated to improving the quality of human life by developing and delivering effective means to prevent, control and ultimately cure cancer. Visit Massey online at www.massey.vcu.edu or call 877-4-MASSEY for more information.

About VCU and the VCU Medical Center

Virginia Commonwealth University is a major, urban public research university with national and international rankings in sponsored research. Located on two downtown campuses in Richmond, VCU enrolls more than 32,000 students in 211 certificate and degree programs in the arts, sciences and humanities. Sixty-nine of the programs are unique in Virginia, many of them crossing the disciplines of VCU's 13 schools and one college. MCV Hospitals and the health sciences schools of Virginia Commonwealth University compose the VCU Medical Center, one of the nation's leading academic medical centers. For more, see www.vcu.edu.

END



ELSE PRESS RELEASES FROM THIS DATE:

GI societies issue new colonoscopy surveillance guidelines

2012-10-02
Bethesda, MD (Oct. 1, 2012) — Patients at average risk of colorectal cancer who have a clean colonoscopy do not need to repeat the test for 10 years. This and many other practical recommendations for cancer prevention were issued in "Guidelines for Colonoscopy Surveillance After Screening and Polypectomy,"1 a consensus update issued by the U.S. Multisociety Task Force on Colorectal Cancer. Colorectal cancer is preventable when precancerous polyps (growths) are found and removed before they turn into cancer. Screening for average risk patients is recommended to begin ...

New technologies advance livestock genomics for agricultural and biomedical uses

2012-10-02
MINNEAPOLIS / ST. PAUL (10/01/2012) —New genome editing technologies developed at the University of Minnesota for use on livestock will allow scientists to learn more about human diseases. The genomic technique, known as TALENS, is described in a report published today in the scientific journal Proceedings of the National Academy of Sciences. The technique is cheaper and faster than previous technologies that allow scientists to genetically modify livestock animals; the animals are used to learn more about human diseases, which in turn can help researchers develop cures. ...

The obese brain may thwart weight loss

2012-10-02
"Betcha can't eat just one!" For obese people trying to lose weight, the Lays potato chip advertising slogan hits a bit too close to home as it describes the daily battle to resist high calorie foods. But new research by Terry Davidson, director of American University's Center for Behavioral Neuroscience, indicates that diets that lead to obesity—diets high in saturated fat and refined sugar—may cause changes to the brains of obese people that in turn may fuel overconsumption of those same foods and make weight loss more challenging. "It is a vicious cycle that may ...

NASA sees Nadine weaken to a tropical storm again

NASA sees Nadine weaken to a tropical storm again
2012-10-02
NASA satellites continue to watch the long-lived Nadine in the eastern Atlantic. Today, Oct. 1, NASA satellite data revealed that Nadine has weakened from a hurricane and is now a tropical storm. Over the weekend of Sept. 29 and 30, Hurricane Nadine dramatically rebounded. On September 19, 2012 Nadine appeared to be dissipating quickly and was expected to become post-tropical but after over a week of meandering near the Azores, Nadine sprang to life again as a hurricane on Friday September 28, 2012. NASA's Tropical Rainfall Measuring Mission (TRMM) satellite's path ...

NASA observes another tropical depression birth in northwestern Pacific

NASA observes another tropical depression birth in northwestern Pacific
2012-10-02
The twenty-first tropical depression of the northwestern Pacific Ocean was born as a NASA satellite flew overhead on Oct. 1, capturing its "baby picture" in infrared light. On Monday, Oct. 1 at 1500 UTC (11 a.m. EDT), Tropical Depression 21W (TD21W) had maximum sustained winds near 25 knots. It was centered about300 nautical miles south of Hong Kong, near 17.4 North latitude and 114.8 East longitude. TD21W has tracked northward at 5 knots and is expected to curve to the northwest and west. On Oct. 1, 2012, infrared imagery from the Atmospheric Infrared Sounder (AIRS) ...

Tropical Storm Maliksi forms, Iwo To on guard

Tropical Storm Maliksi forms, Iwo To on guard
2012-10-02
The western North Pacific is in full swing, tropically speaking and NASA observed the birth of Tropical Storm Maliksi on Sept. 30. NASA's Aqua satellite captured an infrared image of the storm when it was a depression and revealed a large area of powerful thunderstorms around its center that hinted at its strengthening. Tropical Storm Maliksi formed from the twentieth tropical depression of the western North Pacific typhoon season. Tropical Depression 20W formed on Sept. 20 about 305 nautical miles from Guam near 16.3 North and 149.0 East. It is moving to the north-northwest ...

Digital mammography improves population-based breast cancer screening

2012-10-02
OAK BROOK, Ill. – New research from the Netherlands shows that the switch from screen film mammography (SFM) to digital mammography (DM) in large, population-based breast cancer screening programs improves the detection of life-threatening cancer without significantly increasing detection of clinically insignificant disease. Results of the study are published online in the journal Radiology. DM's higher sensitivity at detecting breast cancer raised concerns that its introduction into screening programs would increase the diagnosis of clinically unimportant cancers—cancers ...

Novel MRI technique could reduce breast biopsies

2012-10-02
OAK BROOK, Ill. – Water diffusion measurements with MRI could decrease false-positive breast cancer results and reduce preventable biopsies, according to a new study published online in the journal Radiology. Researchers said the technique also could improve patient management by differentiating high-risk lesions requiring additional workup from other non-malignant subtypes. Dynamic contrast-enhanced MRI (DCE-MRI) has emerged in recent years as a useful tool in breast cancer detection and staging. One of its primary limitations is a substantial number of false-positive ...

PETA scientists analyze animal use in HPV chemicals challenge program

2012-10-02
Washington — In an article published today (October 2, 2012) in the peer-reviewed journal Environmental Health Perspectives (EHP), People for the Ethical Treatment of Animals reports that the U.S. Environmental Protection Agency (EPA) High Production Volume (HPV) Chemicals Challenge Program had the potential to use 3.5 million animals in new testing, but after the application of animal-saving measures, approximately 127,000 were actually used. Although this toll in animal lives is high, it would have been many times worse had PETA not obtained major concessions from the ...

Provincial effort to improve stroke care in Alberta is 'paying off'

2012-10-02
Stroke care has improved considerably in Alberta following the implementation of the Alberta Provincial Stroke Strategy (APSS), leading to more targeted patient care and fewer health complications, according to a study presented today at the Canadian Stroke Congress. Nearly 97 per cent of stroke patients received a brain-imaging scan during their admission to hospital in 2011, compared to 88 per cent before the APSS was implemented in 2006. "The faster a patient has access to brain imaging, the faster they get the right diagnosis and the right treatment," says lead ...

LAST 30 PRESS RELEASES:

New strategies to enhance chiral optical signals unveiled

Cambridge research uncovers powerful virtual reality treatment for speech anxiety

2025 Gut Microbiota for Health World Summit to spotlight groundbreaking research

International survey finds that support for climate interventions is tied to being hopeful and worried about climate change

Cambridge scientist launches free VR platform that eliminates the fear of public speaking

Open-Source AI matches top proprietary model in solving tough medical cases

Good fences make good neighbors (with carnivores)

NRG Oncology trial supports radiotherapy alone following radical hysterectomy should remain the standard of care for early-stage, intermediate-risk cervical cancer

Introducing our new cohort of AGA Future Leaders

Sharks are dying at alarming rates, mostly due to fishing. Retention bans may help

Engineering excellence: Engineers with ONR ties elected to renowned scientific academy

New CRISPR-based diagnostic test detects pathogens in blood without amplification

Immunotherapy may boost KRAS-targeted therapy in pancreatic cancer

Growing solar: Optimizing agrivoltaic systems for crops and clean energy

Scientists discover how to reactivate cancer’s molecular “kill switch”

YouTube influencers: gaming’s best friend or worst enemy?

uOttawa scientists use light to unlock secret of atoms

NJIT mathematician to help map Earth's last frontier with Navy grant

NASA atmospheric wave-studying mission releases data from first 3,000 orbits

‘Microlightning’ in water droplets may have sparked life on Earth

Smoke from wildland-urban interface fires more deadly than remote wildfires

What’s your body really worth? New AI model reveals your true biological age from 5 drops of blood

Protein accidentally lassos itself, helping explain unusual refolding behavior

With bird flu in raw milk, many in U.S. still do not know risks of consuming it

University of Minnesota research team awarded $3.8 million grant to develop cell therapy to combat Alzheimer’s disease

UConn uncovers new clue on what is leading to neurodegenerative diseases like Alzheimer’s and ALS

Resuscitation in out-of-hospital cardiac arrest – it’s how quickly it is done, rather than who does it

A closer look at biomolecular ‘silly putty’

Oxytocin system of breastfeeding affected in mothers with postnatal depression

Liquid metal-enabled synergetic cooling and charging: a leap forward for electric vehicles

[Press-News.org] Researchers harness the immune system to improve stem cell transplant outcomes